Literature DB >> 22876161

Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast dcis: case and review.

B D Jakubovic1, H F Sawires, D N Adam.   

Abstract

Paraneoplastic acanthosis nigricans (pan) is an infrequently encountered cutaneous manifestation of internal malignancy. Here, we describe a case of pan in the setting of a known breast ductal carcinoma in situ, which, to our knowledge, had not been described in association with pan. As a result, thorough investigation was undertaken to search for another concurrent neoplasm that would better explain the development of pan. In so doing, we identified a coexisting metastatic cholangiocarcinoma. We thus conclude that when pan is observed in an uncommon association with a known malignancy, further investigation should be undertaken to explore whether a more likely occult culprit exists.

Entities:  

Keywords:  Acanthosis nigricans; cholangiocarcinoma; ductal carcinoma in situ; paraneoplastic acanthosis nigricans

Year:  2012        PMID: 22876161      PMCID: PMC3410844          DOI: 10.3747/co.19.997

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  19 in total

1.  Oral acanthosis nigricans, the sign of Leser-Trélat and cholangiocarcinoma.

Authors:  C Scully; W A Barrett; J Gilkes; M Rees; M Sarner; R J Southcott
Journal:  Br J Dermatol       Date:  2001-09       Impact factor: 9.302

2.  Malignant acanthosis nigricans in adrenal carcinoma.

Authors:  M Hiranandani; I Kaur; S C Singhi; U Bhoria
Journal:  Indian Pediatr       Date:  1995-08       Impact factor: 1.411

3.  Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes.

Authors:  D L Ellis; S P Kafka; J C Chow; L B Nanney; W H Inman; M E McCadden; L E King
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

Review 4.  Coexistence of acanthosis nigricans and the sign of Leser-Trélat in a patient with gastric adenocarcinoma: a case report and literature review.

Authors:  J S Yeh; S E Munn; T A Plunkett; P G Harper; D J Hopster; A W du Vivier
Journal:  J Am Acad Dermatol       Date:  2000-02       Impact factor: 11.527

5.  Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus.

Authors:  S Koyama; K Ikeda; M Sato; K Shibahara; K Yuhara; H Fukutomi; K Fukunaga; N Kanazawa; K Yuzawa; K Fukao; T Iijima; M Kikuchi; T Tomiya; K Fujiwara
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

Review 6.  Acanthosis nigricans with endometrial carcinoma: case report and review of the literature.

Authors:  Tarek M Mekhail; Maurie Markman
Journal:  Gynecol Oncol       Date:  2002-02       Impact factor: 5.482

7.  Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature.

Authors:  Mehdi M Kebria; Jerome Belinson; Robert Kim; Tarek M Mekhail
Journal:  Gynecol Oncol       Date:  2006-01-27       Impact factor: 5.482

8.  Spectrum of endocrine abnormalities associated with acanthosis nigricans.

Authors:  L Y Matsuoka; J Wortsman; J R Gavin; J Goldman
Journal:  Am J Med       Date:  1987-10       Impact factor: 4.965

9.  Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma.

Authors:  M Pentenero; M Carrozzo; M Pagano; S Gandolfo
Journal:  Int J Dermatol       Date:  2004-07       Impact factor: 2.736

10.  Acanthosis nigricans.

Authors:  R A Schwartz
Journal:  J Am Acad Dermatol       Date:  1994-07       Impact factor: 11.527

View more
  1 in total

Review 1.  An approach to acanthosis nigricans.

Authors:  Meghana Madhukar Phiske
Journal:  Indian Dermatol Online J       Date:  2014-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.